These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19610262)

  • 1. Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting.
    Yonekura S; Okamoto Y; Okubo K; Okawa T; Gotoh M; Suzuki H; Kakuma T; Horiguchi S; Hanazawa T; Konno A; Okuda M
    J Investig Allergol Clin Immunol; 2009; 19(3):195-203. PubMed ID: 19610262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay of onset of symptoms of Japanese cedar pollinosis by treatment with a leukotriene receptor antagonist.
    Gotoh M; Suzuki H; Okubo K
    Allergol Int; 2011 Dec; 60(4):483-9. PubMed ID: 21778814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cedar and cypress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists.
    Sasaki K; Okamoto Y; Yonekura S; Okawa T; Horiguchi S; Chazono H; Hisamitsu M; Sakurai D; Hanazawa T; Okubo K
    Int Arch Allergy Immunol; 2009; 149(4):350-8. PubMed ID: 19295239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber.
    Wakabayashi K; Hashiguchi K; Kanzaki S; Fujioka M; Tanaka N; Kawashima K; Suematsu K; Yamamotoya H; Iwasaki M; Gotoh M; Horibe S; Naito K; Okubo K
    Allergy Asthma Proc; 2012; 33(1):102-9. PubMed ID: 22370535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pranlukast hydrate on airway hyperresponsiveness in non-asthmatic patients with Japanese cedar pollinosis.
    Sagara H; Yukawa T; Kashima R; Okada T; Fukuda T
    Allergol Int; 2009 Jun; 58(2):277-87. PubMed ID: 19390239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis.
    Okubo K; Hashiguchi K; Takeda T; Baba K; Kitagoh H; Miho H; Tomomatsu H; Yamaguchi S; Odani M; Yamamotoya H
    Allergy; 2017 Oct; 72(10):1565-1575. PubMed ID: 28378369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
    Okubo K; Baba K
    Allergol Int; 2008 Dec; 57(4):383-90. PubMed ID: 18946234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis.
    Gotoh M; Okubo K; Hashiguchi K; Wakabayashi K; Kanzaki S; Tanaka N; Fujioka M; Kawashima K; Suematsu K; Sasaki K; Iwasaki M; Yamamotoya H
    Allergy Asthma Proc; 2012; 33(6):459-66. PubMed ID: 23394502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
    J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen.
    Hyo S; Fujieda S; Kawada R; Kitazawa S; Takenaka H
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):457-64. PubMed ID: 15875527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the experimental allergic rhinitis induced by Japanese cedar pollen--role of cysteinyl leukotrienes in nasal allergic symptoms].
    Mizutani N
    Yakugaku Zasshi; 2003 Jan; 123(1):1-8. PubMed ID: 12607939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EFFECT OF PROPHYLACTIC TREATMENT BY LEUKOTORIENE RECEPTOR ANTAGONIST ON JAPANESE CEDAR POLLINOSIS OF PRE- AND POST-SCHOOL CHILDREN JAPANESE CEDAR POLLINOSIS].
    Matsune S; Saruya S; Sawaki S; Otsuka H; Oyama Y; Minowa H; Koyama M; Ikui A; Yoshioka Y; Wakayama N; Ishida M; Sekine K; Yamaguchi S; Okubo K
    Arerugi; 2016 Feb; 65(1):57-65. PubMed ID: 26923655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season.
    Okubo K; Gotoh M; Shimada K; Ritsu M; Okuda M; Crawford B
    Int Arch Allergy Immunol; 2005 Feb; 136(2):148-54. PubMed ID: 15650312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis.
    Okubo K; Nakashima M; Miyake N; Komatsubara M; Okuda M
    Allergy Asthma Proc; 2009; 30(1):84-94. PubMed ID: 19061537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial.
    Kawai M; Hirano T; Arimitsu J; Higa S; Kuwahara Y; Hagihara K; Shima Y; Narazaki M; Ogata A; Koyanagi M; Kai T; Shimizu R; Moriwaki M; Suzuki Y; Ogino S; Kawase I; Tanaka T
    Int Arch Allergy Immunol; 2009; 149(4):359-68. PubMed ID: 19295240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber.
    Endo S; Gotoh M; Okubo K; Hashiguchi K; Suzuki H; Masuyama K
    J Drug Assess; 2012; 1(1):48-54. PubMed ID: 27536428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Yamamoto H; Yamada T; Kubo S; Osawa Y; Kimura Y; Oh M; Susuki D; Takabayashi T; Okamoto M; Fujieda S
    Allergy Asthma Proc; 2010; 31(4):296-303. PubMed ID: 20819319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of quality of life (QOL) and efficacy of drug therapy on nasal symptoms and QOL disturbances in the patients with Japanese Cedar Pollinosis during the season of 2003 in Kyushu and Okinawa districts].
    Ishikawa T; Soh N
    Arerugi; 2004 Nov; 53(11):1131-43. PubMed ID: 15719651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.